UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

EE51 Cost-Effectiveness of Esketamine Nasal Spray Compared to Intravenous Ketamine for Patients with Treatment-Resistant Depression in the US Utilizing Clinical Trial Efficacy and Real-World Effectiveness Estimates

Value in health, 2022-07, Vol.25 (7), p.S345

2022

Volltextzugriff (PDF)

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

PloS one, 2016-10, Vol.11 (10), p.e0164972

2016

Volltextzugriff (PDF)

SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States

Value in health, 2024-06, Vol.27 (6), p.S401-S401

2024

Volltextzugriff (PDF)

An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

Value in health, 2018-05, Vol.21, p.S167

2018

Volltextzugriff (PDF)

Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

Value in health, 2018-05, Vol.21, p.S90

2018

Volltextzugriff (PDF)

PHP15 - The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

Value in health, 2018-05, Vol.21, p.S90-S90

2018

Volltextzugriff (PDF)

PHP14 - Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

Value in health, 2018-05, Vol.21, p.S90-S90

2018

Volltextzugriff (PDF)

The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

Value in health, 2018-05, Vol.21, p.S90

2018

Volltextzugriff (PDF)

PMD50 - An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

Value in health, 2018-05, Vol.21, p.S167-S167

2018

Volltextzugriff (PDF)

CO64 Risk of Bleeding Among Individuals Receiving Oral Anticoagulants with Known Bleeding Risk Factors

Value in health, 2022-07, Vol.25 (7), p.S316

2022

Volltextzugriff (PDF)

EPH107 An Evaluation of the Relationship between QTc Prolonging Medications, Tisdale Risk Scores and Mortality Using a Nationally Representative Electronic Health Records Database

Value in health, 2022-07, Vol.25 (7), p.S454

2022

Volltextzugriff (PDF)

EE429 A Systematic Review of Healthcare Resource Use and Costs of the Treatment of Clostridioides Difficile Infections

Value in health, 2022-07, Vol.25 (7), p.S419

2022

Volltextzugriff (PDF)

EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5–17 Years: A Study of Reports from the VAERS Database

Value in health, 2022-07, Vol.25 (7), p.S460-S460

2022

Volltextzugriff (PDF)

EE479 Cost-Effectiveness of Olaparib Compared to Rucaparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in United States

Value in health, 2022-07, Vol.25 (7), p.S428-S429

2022

Volltextzugriff (PDF)

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions

JAMA network open, 2019-03, Vol.2 (3), p.e190968-e190968

2019

Volltextzugriff (PDF)

AN EVALUATION OF THE IMPACT OF STATIN DRUG-DRUG INTERACTIONS LEADING TO RHABDOMYOLYSIS REQUIRING HOSPITALIZATION

Value in health, 2017-05, Vol.20 (5), p.A143

2017

Volltextzugriff (PDF)

EE2 A Cost-Effectiveness Analysis Comparing Obesity Drug Treatments from a U.S. Payer Perspective

Value in health, 2022-07, Vol.25 (7), p.S335

2022

Volltextzugriff (PDF)

EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

Value in health, 2022-07, Vol.25 (7), p.S466-S466

2022

Volltextzugriff (PDF)

CO51 A Real-World Retrospective Study Evaluating Safety, Effectiveness, and Cost of Intranasal Esketamine for Treatment-Resistant Depression

Value in health, 2022-07, Vol.25 (7), p.S313

2022

Volltextzugriff (PDF)

CO150 Examining the Relationship between Prolonged QTc Risk Score and in-Hospital Mortality

Value in health, 2022-07, Vol.25 (7), p.S332

2022

Volltextzugriff (PDF)

AN EVALUATION OF INJECTABLE DRUG PRICES DURING TIMES OF SHORTAGE IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A27

2017

Volltextzugriff (PDF)

Excessive Antibiotic Use for Acute Respiratory Infections in the United States

Clinical infectious diseases, 2001-09, Vol.33 (6), p.757-762

2001

Volltextzugriff (PDF)

PCR176 Time Trade-Off Utility Values for Health States Characterizing Progressive Muscular Degeneration in Duchenne Muscular Dystrophy (DMD)

Value in health, 2022-07, Vol.25 (7), p.S574

2022

Volltextzugriff (PDF)

PCR105 The Impact of Key Health State Transitions on Health-Related Quality of Life (HRQOL) in Duchenne Muscular Dystrophy (DMD): A Qualitative Study

Value in health, 2022-07, Vol.25 (7), p.S560-S561

2022

Volltextzugriff (PDF)

Impact of Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy on Health Care Costs

The journal of pain, 2010-04, Vol.11 (4), p.360-368

2010

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

EE51 Cost-Effectiveness of Esketamine Nasal Spray Compared to Intravenous Ketamine for Patients with Treatment-Resistant Depression in the US Utilizing Clinical Trial Efficacy and Real-World Effectiveness Estimates

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States

An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

PHP15 - The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

PHP14 - Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

PMD50 - An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

CO64 Risk of Bleeding Among Individuals Receiving Oral Anticoagulants with Known Bleeding Risk Factors

EPH107 An Evaluation of the Relationship between QTc Prolonging Medications, Tisdale Risk Scores and Mortality Using a Nationally Representative Electronic Health Records Database

EE429 A Systematic Review of Healthcare Resource Use and Costs of the Treatment of Clostridioides Difficile Infections

EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5–17 Years: A Study of Reports from the VAERS Database

EE479 Cost-Effectiveness of Olaparib Compared to Rucaparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in United States

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions

AN EVALUATION OF THE IMPACT OF STATIN DRUG-DRUG INTERACTIONS LEADING TO RHABDOMYOLYSIS REQUIRING HOSPITALIZATION

EE2 A Cost-Effectiveness Analysis Comparing Obesity Drug Treatments from a U.S. Payer Perspective

EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

CO51 A Real-World Retrospective Study Evaluating Safety, Effectiveness, and Cost of Intranasal Esketamine for Treatment-Resistant Depression

CO150 Examining the Relationship between Prolonged QTc Risk Score and in-Hospital Mortality

AN EVALUATION OF INJECTABLE DRUG PRICES DURING TIMES OF SHORTAGE IN THE UNITED STATES

Excessive Antibiotic Use for Acute Respiratory Infections in the United States

PCR176 Time Trade-Off Utility Values for Health States Characterizing Progressive Muscular Degeneration in Duchenne Muscular Dystrophy (DMD)

PCR105 The Impact of Key Health State Transitions on Health-Related Quality of Life (HRQOL) in Duchenne Muscular Dystrophy (DMD): A Qualitative Study

Impact of Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy on Health Care Costs

Suchergebnisse filtern